Macrolid-S

Roxithromycin, the active ingredient in Macrolid-S, is a macrolide antibiotic presented as an oral dosage form for oral use. It treats a range of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Macrolid-S as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Roxithromycin is employed to manage bacterial infections affecting various organ systems.

- Community‑acquired pneumonia: effective against susceptible bacterial pathogens causing lung infection. - Acute bacterial bronchitis: reduces symptoms and bacterial load in the airways. - Skin and soft‑tissue infections: treats cellulitis and other dermal infections caused by susceptible organisms. - Uncomplicated urinary tract infections: eradicates common uropathogens when indicated.

Roxithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools occurring during therapy. - Abdominal pain: cramping or discomfort in the stomach area. - Dyspepsia: indigestion or heartburn. - Headache: transient mild headache. - Altered taste: temporary metallic or bitter taste.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis. - Stevens‑Johnson syndrome: rare skin blistering disorder. - Hematologic abnormalities: neutropenia or thrombocytopenia.

Before prescribing Roxithromycin, clinicians should consider several safety factors.

- Renal impairment: assess kidney function and adjust if necessary. - Hepatic disease: use with caution in patients with liver dysfunction. - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Concomitant QT‑prolonging drugs: monitor cardiac rhythm closely. - Drug‑interaction potential: review patient’s medication list for interacting agents. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Roxithromycin can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Warfarin: may increase anticoagulant effect and bleeding risk. - Drugs that prolong QT interval (e.g., certain antipsychotics): heightened risk of arrhythmia.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may raise roxithromycin plasma levels. - CYP3A4 inducers (e.g., rifampicin): may reduce therapeutic effectiveness. - Antacids containing aluminum or magnesium: can decrease absorption if taken simultaneously.